Literature DB >> 15141754

Background on methods of stimulation in galvanic-induced body sway in young healthy adults.

Susan G T Balter1, Robert J Stokroos, Iwan De Jong, Rob Boumans, Maikel Van de Laar, Herman Kingma.   

Abstract

The aim of this study was to develop a standardized procedure for reproducible quantification of galvanic-induced body sway (GBS). This was a prospective experimental study conducted in a tertiary referral centre. An exploratory study was first conducted to define the galvanic vestibular stimulation (GVS) method that resulted in the best reproducible responses. Ten subjects underwent computer-controlled GVS using five different types of monaural and binaural stimulation with 2-mA currents. Cosinusoidal stimulation gave the most reproducible responses. The frequency and current variability of this stimulus type were then tested in the same 10 subjects. A monaural continuous 1-cosinusoidal current of 0.5 Hz and 2 mA gave the most reproducible responses (< 20% test-retest variation) and the largest GBS amplitude. The other (sinusoidal) stimuli resulted in variabilities exceeding 50%. This stimulus was thus used for further testing in our normative study. In this study we measured GBS amplitude at 0.5 Hz in 60 subjects, with eyes closed and an inter-feet distance of 0 cm, using a force platform. In addition to body sway, responses included slight dizziness, taste sensations and a tingling sensation at the site of stimulation. Habituation to the applied stimulus was seen. Binaural prestimulation, performed in 50/60 test subjects, is necessary to reduce habituation and achieve optimal reproducibility in order to be able to compare the sensitivity of the left and right vestibular systems. The test-retest variability was determined in detail in 12 additional subjects. Prestimulation reduced habituation, but improved the sensitivity of the method; some test-retest variability persisted (< 20%).

Entities:  

Mesh:

Year:  2004        PMID: 15141754     DOI: 10.1080/00016480310015245

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  7 in total

1.  Modeling postural instability with Galvanic vestibular stimulation.

Authors:  Hamish G MacDougall; Steven T Moore; Ian S Curthoys; F Owen Black
Journal:  Exp Brain Res       Date:  2006-01-24       Impact factor: 1.972

2.  Impaired neuromotor functions in hospital laboratory workers exposed to low levels of organic solvents.

Authors:  Guillaume Herpin; Gerome C Gauchard; Alexandre Vouriot; Bernard Hannhart; Alain Barot; Jean-Marie Mur; Denis Zmirou-Navier; Philippe P Perrin
Journal:  Neurotox Res       Date:  2008 May-Jun       Impact factor: 3.911

3.  Sensitivity of local dynamic stability of over-ground walking to balance impairment due to galvanic vestibular stimulation.

Authors:  Lizeth H Sloot; Kimberley S van Schooten; Sjoerd M Bruijn; Herman Kingma; Mirjam Pijnappels; Jaap H van Dieën
Journal:  Ann Biomed Eng       Date:  2011-01-11       Impact factor: 3.934

4.  Neuroimaging to detect cortical projection of vestibular response to caloric stimulation in young and older adults using functional near-infrared spectroscopy (fNIRS).

Authors:  H T Karim; S I Fuhrman; J M Furman; T J Huppert
Journal:  Neuroimage       Date:  2013-03-22       Impact factor: 6.556

5.  The vestibular implant: quo vadis?

Authors:  Raymond van de Berg; Nils Guinand; Robert J Stokroos; Jean-Philippe Guyot; Herman Kingma
Journal:  Front Neurol       Date:  2011-08-11       Impact factor: 4.003

6.  Fractal analyses reveal independent complexity and predictability of gait.

Authors:  Frédéric Dierick; Anne-Laure Nivard; Olivier White; Fabien Buisseret
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

7.  Vestibular attenuation to random-waveform galvanic vestibular stimulation during standing and treadmill walking.

Authors:  Kelci B Hannan; Makina K Todd; Nicole J Pearson; Patrick A Forbes; Christopher J Dakin
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.